Tests for the detection of the monkeypox virus will be reimbursed 100% by Health Insurance, indicates this Saturday a decree in the Official Journal, after a recommendation to this effect from the High Authority for Health.
“The development of the monkeypox epidemic implies being able to confirm cases of infection in the absence of a sufficiently explicit clinical picture” and nucleic acid amplification tests (NAAT) (a technique that includes PCR tests) “Allow infections to be confirmed”, underlines this decree. “It is therefore appropriate that these screening tests be covered by Health Insurance”, continues the text.
Limitation to “suspected cases” and “possible cases”
Monday the High Authority for Health had decided for the reimbursement by the Health Insurance of the tests, after having been seized by the Ministry of Health on the question.
The High Authority for Health had recalled that the diagnosis is based first on the examination and questioning of the patient, specifying that “detection by NAAT test should only be carried out in the event of persistent doubt after clinical examination” for ” whether or not to confirm » the infection.
“The use of this type of test is thus limited to” suspected cases “and” possible cases “, as defined by Public Health France and is not necessary in the absence of symptoms”, had specified the health authority.